4
Changes in Ownership
ACADIA PHARMACEUTICALS INC Filed Acc 0001209191-21-002836
EVP and CCO sold 1,120 shares at $53.34 ($59,741)
- EVP and CCO acquired 2,722 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| YANG MICHAEL J. EVP and CCO | 2021-01-06 | Option exercise | +2,722 | 9,179 | D | ||
| YANG MICHAEL J. EVP and CCO | 2021-01-06 | Sale | −1,120 | $53.34 | $59,741 | 8,059 | D |
| Derivatives | |||||||
| YANG MICHAEL J. EVP and CCO | 2021-01-06 | Option exercise · Restricted Stock Units | −2,722 | 8,167 | D | ||
| Open-market sales · 1,120 sh · avg $53.34 · $59,741 | |||||||
Loading xslF345X03/doc4.xml…